Merck chief executive signals interest in medical devices

Share this article:
Merck chief executive Richard Clark told analysts Friday he might consider expanding into medical devices and diagnostics as a way to revive the company's fortunes.
Clark mapped out the options for the company in a private meeting with analysts on Friday, Reuters said. The newly-appointed Merck chief told analysts that change has to come but change "is not synonymous with cutting costs."
A Merck spokeswoman confirmed to Reuters the meeting took place, adding that the drug maker is "examining options" but that no decisions have been made.
Meanwhile, closing arguments are scheduled for today in Merck's second Vioxx trial being held in Atlantic City, New Jersey.
Lawyers for Merck and Frederick "Mike" Humeston, a postal worker suing the company over Vioxx, met privately with the judge in the case on Friday to negotiate the wording of instructions given to jurors before they star deliberating.
Share this article:

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...